• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Highlights in prostate cancer from the 2011 American Urological Association Annual Meeting and the 2011 American Society of Clinical Oncology Annual Meeting.

作者信息

Yu Evan Y

机构信息

University of Washington/Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington.

出版信息

Clin Adv Hematol Oncol. 2011 Aug;9(8 Suppl 21):1-24.

PMID:22362073
Abstract
摘要

相似文献

1
Highlights in prostate cancer from the 2011 American Urological Association Annual Meeting and the 2011 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol. 2011 Aug;9(8 Suppl 21):1-24.
2
Highlights in advanced prostate cancer from the 2013 American Society of Clinical Oncology Genitourinary Cancers Symposium.2013年美国临床肿瘤学会泌尿生殖系统癌症研讨会中晚期前列腺癌的要点
Clin Adv Hematol Oncol. 2013 Apr;11(4 Suppl 7):1-22.
3
Highlights in advanced prostate cancer from the 2012 American Urological Association Annual Meeting and the 2012 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol. 2012 Aug;10(8 Suppl 12):1-24.
4
Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting.前列腺癌研究：下一代；2019 年科菲-霍尔顿前列腺癌学会会议报告。
Prostate. 2020 Feb;80(2):113-132. doi: 10.1002/pros.23934. Epub 2019 Dec 11.
5
Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.超越雄激素受体II：理解和治疗转移性前列腺癌的新方法；2017年科菲-霍尔登前列腺癌学术会议报告
Prostate. 2017 Nov;77(15):1478-1488. doi: 10.1002/pros.23424. Epub 2017 Sep 18.
6
Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.肿瘤细胞异质性与耐药性：2018 年科菲-霍尔顿前列腺癌学会会议报告。
Prostate. 2019 Feb;79(3):244-258. doi: 10.1002/pros.23729. Epub 2018 Oct 31.
7
Current management of advanced and castration resistant prostate cancer.晚期及去势抵抗性前列腺癌的当前管理
Can J Urol. 2014 Apr;21(2 Supp 1):1-6.
8
Caveolin-1 as a biomarker to predict therapeutic effect of low-frequency ultrasound combined with SonoVue on prostate cancer in nude mice model.小窝蛋白-1作为预测低频超声联合声诺维对裸鼠模型前列腺癌治疗效果的生物标志物。
Cancer Biomark. 2014;14(4):279-86. doi: 10.3233/CBM-140405.
9
Targeted PET imaging for prostate-specific membrane antigen in prostate cancer.前列腺癌中前列腺特异性膜抗原的靶向正电子发射断层显像
Future Oncol. 2016 Nov;12(21):2393-2396. doi: 10.2217/fon-2016-0312. Epub 2016 Jul 25.
10
[Androgen receptor variants in prostate cancer].[前列腺癌中的雄激素受体变体]
Med Sci (Paris). 2017 Aug-Sep;33(8-9):758-764. doi: 10.1051/medsci/20173308021. Epub 2017 Sep 18.